19207.jpg
Explain
This image is a comparison chart of Multiple Endocrine Neoplasia (MEN) Syndromes. Here is a detailed breakdown:
What are MEN Syndromes?
MEN syndromes are a group of autosomal dominant inherited disorders that cause tumors in multiple endocrine glands simultaneously. They are high-yield topics for medical exams (NEET PG, INI-CET, FMGE).
MEN 1 - Wermer Syndrome
- Gene: MEN1 (tumor suppressor gene on chromosome 11q13)
- Mnemonic: "1 = PPP" - Pituitary + Parathyroid + Pancreas
- Clinical Features:
- Pituitary adenomas - prolactinoma (most common), GH-secreting, ACTH-secreting
- Parathyroid hyperplasia/adenoma - causing primary hyperparathyroidism (most common manifestation, ~95% of cases)
- Pancreatic neuroendocrine tumors (NETs) - Gastrinoma (most common pancreatic tumor in MEN1), Insulinoma, VIPoma, Glucagonoma
- Adrenal tumors (less common)
- Carcinoid tumors
- Key Highlights:
- Most common MEN syndrome overall
- Parathyroid disease has the highest incidence
- Pancreatic NETs are very common and clinically significant
MEN 2A - Sipple Syndrome
- Gene: RET proto-oncogene (gain-of-function mutation)
- Mnemonic: "2A = 3 P's" - Parathyroid + Pheochromocytoma + Pituitary (via MTC stimulation)
- Clinical Features:
- Medullary thyroid carcinoma (MTC) - universal (100% penetrance)
- Pheochromocytoma - bilateral adrenal in 30-50%
- Primary hyperparathyroidism - in ~20-30%
- Key Highlights:
- MTC is universal - prophylactic thyroidectomy is recommended in gene carriers
- Always screen for pheochromocytoma BEFORE any surgery (to avoid hypertensive crisis)
MEN 2B (also called MEN 3)
- Gene: RET proto-oncogene (different mutation than 2A, typically M918T)
- Mnemonic: "2B = 3 M's" - MTC + Mucosal neuromas + Marfanoid habitus
- Clinical Features:
- Medullary thyroid carcinoma (MTC) - universal AND more aggressive than MEN 2A
- Pheochromocytoma
- Mucosal neuromas - on lips, tongue, eyelids (pathognomonic finding)
- Marfanoid habitus - tall, slender build, long limbs
- Key Highlights:
- MTC is the most aggressive of all MEN syndromes - presents earliest (even in infancy)
- No parathyroid involvement (unlike 2A)
- Mucosal neuromas are a distinguishing feature from 2A
MEN 4
- Gene: CDKN1B (encodes p27, a cyclin-dependent kinase inhibitor)
- Mnemonic: "4 = PPRR" - Pituitary + Parathyroid + Reproductive + Renal
- Clinical Features:
- Pituitary adenomas
- Parathyroid hyperplasia/adenoma
- Primary hyperparathyroidism
- Reproductive tumors - testicular, ovarian (characteristic feature distinguishing it from MEN 1)
- Key Highlights:
- Phenotypically similar to MEN 1 but caused by a different gene
- Reproductive tumors are the hallmark
- Rarest of the MEN syndromes
Quick Comparison Summary
| Feature | MEN 1 | MEN 2A | MEN 2B | MEN 4 |
|---|---|---|---|---|
| Gene | MEN1 | RET | RET | CDKN1B |
| Parathyroid | Yes | Yes | No | Yes |
| Pituitary | Yes | No | No | Yes |
| Pancreatic NETs | Yes | No | No | No |
| MTC | No | Yes | Yes (aggressive) | No |
| Pheochromocytoma | No | Yes | Yes | No |
| Mucosal neuromas | No | No | Yes | No |
| Marfanoid habitus | No | No | Yes | No |
| Reproductive tumors | No | No | No | Yes |
Key Clinical Pearls
- MEN 1 - Parathyroid is most common; think "PPP"
- MEN 2A vs 2B - Both have MTC + Pheo, but 2B adds mucosal neuromas and marfanoid habitus, and lacks parathyroid involvement
- RET mutation = MEN 2A and 2B; always rule out pheochromocytoma before surgery
- MEN 4 = MEN 1 phenotype but with reproductive tumors and a different gene
- All MEN syndromes follow autosomal dominant inheritance
This is a shared conversation. Sign in to Orris to start your own chat.